If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
333.50    0.00 (0.00%)
Bid:
332.00
Ask:
335.00
Spread: 3.00 (0.904%)
Market Cap: £230.27m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

Form 8.5 (EPT/RI)

9 Jun 2026 12:00

RNS Number : 5719H
Panmure Liberum Limited
09 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Animalcare Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Animalcare Group plc

(d) Date dealing undertaken:

08 Jun 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

20p ordinary

Purchase

6,600

3.3188 GBP

3.3188 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

09/06/2026

Contact name:

Paul Crispin

Telephone number:

+44 (0) 20 7886 2759

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERMZGGVRLZGVZG
Date   Source Headline
14th Sep 20107:00 amRNSPotential disposal
14th Jul 20101:41 pmRNSShare Allotment
14th Jul 201011:15 amRNSHolding(s) in Company
13th Jul 20107:00 amRNSPre-close Trading Statement
9th Jun 201011:51 amRNSHolding(s) in Company
20th Apr 20102:14 pmRNSIssue of Equity
1st Apr 20109:00 amRNSDirectorate Change
8th Mar 20107:00 amRNSDirector/PDMR Shareholding
22nd Feb 20107:30 amRNSDirectorate Change
22nd Feb 20107:00 amRNSInterim Results
14th Jan 20107:00 amRNSIssue of Equity
16th Dec 20095:43 pmRNSDirector/PDMR Shareholding
3rd Dec 200910:08 amRNSHolding(s) in Company
5th Oct 200910:54 amRNSChange of dividend record date
5th Oct 20097:00 amRNSFinal Results
20th Jul 20093:20 pmRNSDirector/PDMR Shareholding
16th Jul 20091:25 pmRNSDirector/PDMR Shareholding
8th Jul 20097:00 amRNSPre-Close Trading Update
16th Jun 20097:00 amRNSNew Appointments
2nd Jun 200911:33 amRNSDirector/PDMR Shareholding
1st Apr 20094:11 pmRNSDirector/PDMR Shareholding
31st Mar 20097:00 amRNSDirectorate Change
31st Mar 20097:00 amRNSHalf Yearly Report
24th Dec 20087:00 amRNSStatement re share price movement
12th Dec 20082:48 pmRNSDirector/PDMR Shareholding
21st Nov 20083:47 pmRNSDirector/PDMR Shareholding
20th Nov 200812:25 pmRNSDirector/PDMR Shareholding
24th Oct 200810:32 amRNSDirector/PDMR Shareholding
23rd Oct 20083:58 pmRNSHolding(s) in Company
6th Oct 20083:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20084:39 pmRNSDirector/PDMR Shareholding
2nd Oct 20089:04 amRNSDirector/PDMR Shareholding
30th Sep 20087:00 amRNSFinal Results
12th Aug 20088:46 amRNSHolding(s) in Company
10th Jul 20087:00 amRNSPre-Close Trading Statement
11th Apr 20084:58 pmRNSBoard appointment
31st Mar 20087:01 amRNSInterim Results
30th Jan 20083:43 pmRNSHolding(s) in Company
25th Jan 20085:04 pmRNSHolding(s) in Company
25th Jan 20085:03 pmRNSHolding(s) in Company
25th Jan 20085:02 pmRNSHolding(s) in Company
25th Jan 20085:01 pmRNSHolding(s) in Company
25th Jan 20085:00 pmRNSHolding(s) in Company
25th Jan 20084:59 pmRNSHolding(s) in Company
15th Jan 200811:07 amRNSChange of Name
15th Jan 20088:00 amRNS1st dealings on AIM
15th Jan 20088:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.